1-155175622-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_025058.5(TRIM46):c.300C>A(p.Asp100Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,613,868 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_025058.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRIM46 | NM_025058.5 | c.300C>A | p.Asp100Glu | missense_variant | 2/10 | ENST00000334634.9 | NP_079334.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRIM46 | ENST00000334634.9 | c.300C>A | p.Asp100Glu | missense_variant | 2/10 | 1 | NM_025058.5 | ENSP00000334657.4 | ||
ENSG00000273088 | ENST00000473363.3 | c.49-2148G>T | intron_variant | 5 | ENSP00000477381.3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152222Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000324 AC: 8AN: 246584Hom.: 0 AF XY: 0.0000447 AC XY: 6AN XY: 134362
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461528Hom.: 0 Cov.: 32 AF XY: 0.0000124 AC XY: 9AN XY: 727062
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152340Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74492
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 05, 2024 | The c.300C>A (p.D100E) alteration is located in exon 2 (coding exon 2) of the TRIM46 gene. This alteration results from a C to A substitution at nucleotide position 300, causing the aspartic acid (D) at amino acid position 100 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at